Literature DB >> 22817456

Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis.

V S Romanov1, V A Pospelov, T V Pospelova.   

Abstract

p21(Waf1) was identified as a protein suppressing cyclin E/A-CDK2 activity and was originally considered as a negative regulator of the cell cycle and a tumor suppressor. It is now considered that p21(Waf1) has alternative functions, and the view of its role in cellular processes has begun to change. At present, p21(Waf1) is known to be involved in regulation of fundamental cellular programs: cell proliferation, differentiation, migration, senescence, and apoptosis. In fact, it not only exhibits antioncogenic, but also oncogenic properties. This review provides a contemporary understanding of the functions of p21(Waf1) depending on its intracellular localization. On one hand, when in the nucleus, it serves as a negative cell cycle regulator and tumor suppressor, in particular by participating in the launch of a senescence program. On the other hand, when p21(Waf1) is localized in the cytoplasm, it acts as an oncogene by regulating migration, apoptosis, and proliferation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817456     DOI: 10.1134/S000629791206003X

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  59 in total

1.  Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Authors:  Madeeha Aqil; Zane Deliu; Kim M Elseth; Grace Shen; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-17

2.  p21 shapes cancer evolution.

Authors:  Vasily S Romanov; K Lenhard Rudolph
Journal:  Nat Cell Biol       Date:  2016-06-28       Impact factor: 28.824

3.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

4.  Tenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in mice.

Authors:  Hanna H Ng; Howard Stock; Linda Rausch; Deborah Bunin; Abraham Wang; Shirley Brill; Jason Gow; Jon C Mirsalis
Journal:  Int J Toxicol       Date:  2015-01-07       Impact factor: 2.032

5.  Prevention of BMS-777607-induced polyploidy/senescence by mTOR inhibitor AZD8055 sensitizes breast cancer cells to cytotoxic chemotherapeutics.

Authors:  Sharad Sharma; Hang-Ping Yao; Yong-Qing Zhou; Jianwei Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Mol Oncol       Date:  2014-01-02       Impact factor: 6.603

6.  Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.

Authors:  Lisa Arzt; Iris Halbwedl; Margit Gogg-Kamerer; Helmut H Popper
Journal:  Pathol Oncol Res       Date:  2016-12-16       Impact factor: 3.201

7.  Correlation between S100A11 and the TGF-β1/SMAD4 pathway and its effects on the proliferation and apoptosis of pancreatic cancer cell line PANC-1.

Authors:  Yi-Fei Ji; Tao Li; Feng Jiang; Wen-Kai Ni; Cheng-Qi Guan; Zhao-Xiu Liu; Cui-Hua Lu; Run-Zhou Ni; Wei Wu; Ming-Bing Xiao
Journal:  Mol Cell Biochem       Date:  2018-06-19       Impact factor: 3.396

8.  Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin.

Authors:  Seo Rin Kim; Kai Jiang; Mikolaj Ogrodnik; Xiaojun Chen; Xiang-Yang Zhu; Hannah Lohmeier; Leena Ahmed; Hui Tang; Tamara Tchkonia; LaTonya J Hickson; James L Kirkland; Lilach O Lerman
Journal:  Transl Res       Date:  2019-07-15       Impact factor: 7.012

Review 9.  Centrosome amplification: a suspect in breast cancer and racial disparities.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Endocr Relat Cancer       Date:  2017-05-17       Impact factor: 5.678

10.  PAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulation.

Authors:  Evan Gomes Giacoia; Makito Miyake; Adrienne Lawton; Steve Goodison; Charles J Rosser
Journal:  Mol Cancer Res       Date:  2014-01-24       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.